tiprankstipranks
Advertisement
Advertisement

SRZN Stock Latest News

Surrozen initiated with an Outperform at William Blair
The FlySurrozen initiated with an Outperform at William Blair
4d ago
SRZN
Analyst Maintains Buy on Surrozen, Reiterates $46 Price Target on Novel Wnt Pathway Strategy in Retinal Disease
PremiumRatings
Analyst Maintains Buy on Surrozen, Reiterates $46 Price Target on Novel Wnt Pathway Strategy in Retinal Disease
6d ago
SRZN
Surrozen: Buy Rating Reiterated as Clinical Roadmap Clarifies and IP Strengthens; Price Target Maintained at $44
PremiumRatings
Surrozen: Buy Rating Reiterated as Clinical Roadmap Clarifies and IP Strengthens; Price Target Maintained at $44
14d ago
SRZN
Patrick Dolezal Reiterates Buy on Surrozen, Keeps Price Target Unchanged at $44 Ahead of Key BRUNELLO Readout
PremiumRatings
Patrick Dolezal Reiterates Buy on Surrozen, Keeps Price Target Unchanged at $44 Ahead of Key BRUNELLO Readout
1M ago
SRZN
Surrozen Shareholders Support Board, Auditor and Pay Policies
PremiumCompany Announcements
Surrozen Shareholders Support Board, Auditor and Pay Policies
3M ago
8K
SRZN
Surrozen price target raised to $44 from $36 at H.C. Wainwright
PremiumThe FlySurrozen price target raised to $44 from $36 at H.C. Wainwright
4M ago
SRZN
Surrozen Earns Buy Rating on Advancing Retinal Pipeline, Strong Cash Runway, and Large wAMD/DME Market Opportunity
Premium
Ratings
Surrozen Earns Buy Rating on Advancing Retinal Pipeline, Strong Cash Runway, and Large wAMD/DME Market Opportunity
4M ago
SRZN
Surrozen reports Q1 EPS ($11.65) vs. ($7.43) last year
Premium
The Fly
Surrozen reports Q1 EPS ($11.65) vs. ($7.43) last year
4M ago
SRZN
Surrozen management to meet with Cantor
PremiumThe Fly
Surrozen management to meet with Cantor
4M ago
SRZN
Surrozen: Buy Rating Reiterated as Analyst Highlights Wnt-Targeted Ophthalmology Strategy and Maintains $37 Price Target
PremiumRatings
Surrozen: Buy Rating Reiterated as Analyst Highlights Wnt-Targeted Ophthalmology Strategy and Maintains $37 Price Target
4M ago
SRZN
Surrozen initiated with a Buy at TD Cowen
PremiumThe Fly
Surrozen initiated with a Buy at TD Cowen
4M ago
SRZN
Surrozen price target raised to $36 from $32 at H.C. Wainwright
PremiumThe Fly
Surrozen price target raised to $36 from $32 at H.C. Wainwright
5M ago
SRZN
Surrozen files $200M mixed securities shelf
PremiumThe FlySurrozen files $200M mixed securities shelf
5M ago
SRZN
Surrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Surrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
5M ago
SRZN
Surrozen initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Surrozen initiated with an Overweight at Cantor Fitzgerald
6M ago
SRZN
Surrozen announces routine board resignation with no disputes
PremiumCompany Announcements
Surrozen announces routine board resignation with no disputes
7M ago
8K
SRZN
Surrozen’s Innovative Wnt-Targeted Therapies Poised to Disrupt $15 Billion Anti-VEGF Market: A Compelling Buy Recommendation
PremiumRatings
Surrozen’s Innovative Wnt-Targeted Therapies Poised to Disrupt $15 Billion Anti-VEGF Market: A Compelling Buy Recommendation
9M ago
SRZN
Surrozen initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Surrozen initiated with an Outperform at LifeSci Capital
9M ago
SRZN
Surrozen, Inc. Reports Significant Q3 2025 Loss
PremiumCompany Announcements
Surrozen, Inc. Reports Significant Q3 2025 Loss
9M ago
SRZN
Surrozen’s Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy Rating
PremiumRatingsSurrozen’s Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy Rating
10M ago
SRZN
Surrozen Appoints Andrew Maleki as New CFO
Premium
Company Announcements
Surrozen Appoints Andrew Maleki as New CFO
10M ago
8K
SRZN
Surrozen names Andrew Maleki as CFO
Premium
The Fly
Surrozen names Andrew Maleki as CFO
10M ago
SRZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >